2019 欧洲共识建议:免疫球蛋白A血管炎的诊断和治疗

2019-03-16 国外风湿免疫科相关专家小组 Rheumatology (Oxford). 2019 Mar 16.

免疫球蛋白A血管炎(IgAV)是儿童时期最常见的全身性血管炎。本文主要针对IgAV的诊断和治疗提出指导建议,共包括7条诊断建议19条儿童IgAV治疗建议。诊断建议涉及恰当应用皮肤和肾脏活检,肾脏检查和影像学检查,治疗建议包括合理月止痛药和血管紧张素转换酶抑制剂以及CS的应用。、

中文标题:

2019 欧洲共识建议:免疫球蛋白A血管炎的诊断和治疗

英文标题:

European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.

发布日期:

2019-03-16

简要介绍:

免疫球蛋白A血管炎(IgAV)是儿童时期最常见的全身性血管炎。本文主要针对IgAV的诊断和治疗提出指导建议,共包括7条诊断建议19条儿童IgAV治疗建议。诊断建议涉及恰当应用皮肤和肾脏活检,肾脏检查和影像学检查,治疗建议包括合理月止痛药和血管紧张素转换酶抑制剂以及CS的应用。、

拓展指南:血管炎相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 欧洲共识建议:免疫球蛋白A血管炎的诊断和治疗)] GetToolGuiderByIdResponse(projectId=1, id=2086f1c001e20527, title=2019 欧洲共识建议:免疫球蛋白A血管炎的诊断和治疗, enTitle=European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative., guiderFrom=Rheumatology (Oxford). 2019 Mar 16., authorId=null, author=, summary=免疫球蛋白A血管炎(IgAV)是儿童时期最常见的全身性血管炎。本文主要针对IgAV的诊断和治疗提出指导建议,共包括7条诊断建议19条儿童IgAV治疗建议。诊断建议涉及恰当应用皮肤和肾脏活检,肾脏检查和影像学检查,治疗建议包括合理月止痛药和血管紧张素转换酶抑制剂以及CS的应用。、 , cover=, journalId=null, articlesId=null, associationId=893, associationName=国外风湿免疫科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Sat Mar 16 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>免疫球蛋白A血管炎(IgAV)是儿童时期最常见的全身性血管炎。本文主要针对IgAV的诊断和治疗提出指导建议,共包括7条诊断建议19条儿童IgAV治疗建议。诊断建议涉及恰当应用皮肤和肾脏活检,肾脏检查和影像学检查,治疗建议包括合理月止痛药和血管紧张素转换酶抑制剂以及CS的应用。、</div> <div><br> </div>拓展指南:<strong>与<font color=red>血管炎</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=af8df1c0016e78d5" title="2018 欧洲共识建议:罕见儿童血管炎的诊断和治疗" target=_blank>2018 欧洲共识建议:罕见儿童血管炎的诊断和治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=0be101c001618844" title="嗜酸性肉芽肿性多血管炎诊治规范多学科专家共识" target=_blank>嗜酸性肉芽肿性多血管炎诊治规范多学科专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=6d5a91c00159629e" title="欧洲抗风湿病联盟关于影像学技术在大血管炎临床实践中的应用推荐" target=_blank>欧洲抗风湿病联盟关于影像学技术在大血管炎临床实践中的应用推荐</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a1e8f1c0015a821a" title="2018 EULAR建议:大血管血管炎影像学检查" target=_blank>2018 EULAR建议:大血管血管炎影像学检查</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=bda351c001a9e798" title="2017 国际共识:多血管炎和显微镜下多血管炎肉芽肿病ANCAs检测" target=_blank>2017 国际共识:多血管炎和显微镜下多血管炎肉芽肿病ANCAs检测</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%A1%80%E7%AE%A1%E7%82%8E" target=_blank>有关血管炎更多指南</a></ul>, tagList=[TagDto(tagId=88357, tagName=免疫球蛋白A血管炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5811, appHits=254, showAppHits=0, pcHits=3966, showPcHits=2898, likes=130, shares=7, comments=2, approvalStatus=1, publishedTime=Tue Apr 02 22:23:48 CST 2019, publishedTimeString=2019-03-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Apr 02 22:23:48 CST 2019, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 08:16:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 欧洲共识建议:免疫球蛋白A血管炎的诊断和治疗)])
2019 欧洲共识建议:免疫球蛋白A血管炎的诊断和治疗
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2145583, encodeId=831221455833a, content=学习使我快乐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d545434460, createdName=ms1000000687639315, createdTime=Fri Jun 30 04:50:58 CST 2023, time=2023-06-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=809840, encodeId=1893809840c3, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c615403200, createdName=ms8000000618836174, createdTime=Mon Aug 17 21:01:12 CST 2020, time=2020-08-17, status=1, ipAttribution=)]
    2023-06-30 ms1000000687639315 来自江苏省

    学习使我快乐

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2145583, encodeId=831221455833a, content=学习使我快乐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d545434460, createdName=ms1000000687639315, createdTime=Fri Jun 30 04:50:58 CST 2023, time=2023-06-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=809840, encodeId=1893809840c3, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c615403200, createdName=ms8000000618836174, createdTime=Mon Aug 17 21:01:12 CST 2020, time=2020-08-17, status=1, ipAttribution=)]
    2020-08-17 ms8000000618836174

    学习了!

    0